Article
[Incidence of amantadine-resistant influenza A (genotype Ser-31-Asn) in nursing homes in Niigata, Japan].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases - 1 Aug 2000
Saito R, Masuda H, Oshitani H, Suzuki H, Kawasaki S, Sato H
Abstract excerpt
The antiviral agent amantadine specifically inhibit influenza A virus infection, but the emergence of drug-resistant viruses occur more readily with amantadine treatment. In human influenza viruses, single amino acid changes at 4 sites spanning the transmembrane domain of the M2 protein can confer drug resistance. Amantadine was approved for treatment of Parkinson's disease in 1975, and for the influenza A virus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
